These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 8581269
21. Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor. Bennett SA, Birnboim HC. Mol Carcinog; 1997 Dec; 20(4):366-75. PubMed ID: 9433481 [Abstract] [Full Text] [Related]
23. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity. Grigoriadis G, Stewart AG. Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761 [Abstract] [Full Text] [Related]
24. Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs. Fiedler VB, Mardin M, Abram TS. Basic Res Cardiol; 1987 Sep; 82(2):197-208. PubMed ID: 3606544 [Abstract] [Full Text] [Related]
25. Existence of PAF receptors in human platelets and human lung tissue but not in the human myocardium. Schwinger RH, Böhm M, La Rosée K, Erdmann E. Am Heart J; 1992 Aug; 124(2):320-30. PubMed ID: 1322030 [Abstract] [Full Text] [Related]
27. Age-related effects of platelet activating factor (PAF) in the isolated perfused rat heart. Abete P, Ferrara N, Leosco D, Caccese P, Landino P, Sederino S, Balbi R, Rengo F. J Mol Cell Cardiol; 1992 Dec; 24(12):1399-407. PubMed ID: 1293314 [Abstract] [Full Text] [Related]
28. Reproducible vasodilatation by platelet-activating factor in blood- and Krebs-perfused rat kidneys is albumin-dependent. Gerkens JF. Eur J Pharmacol; 1990 Feb 27; 177(3):119-26. PubMed ID: 2311673 [Abstract] [Full Text] [Related]
32. Role of platelet-activating factor in long-term potentiation of the rat medial vestibular nuclei. Grassi S, Francescangeli E, Goracci G, Pettorossi VE. J Neurophysiol; 1998 Jun 27; 79(6):3266-71. PubMed ID: 9636125 [Abstract] [Full Text] [Related]
33. Modulation of antigen- and ischemia-induced effects by the platelet-activating factor antagonist WEB-2086 in isolated sensitized rat hearts. Vleeming W, Wemer J, Porsius AJ. J Cardiovasc Pharmacol; 1992 Jun 27; 20(5):790-9. PubMed ID: 1280743 [Abstract] [Full Text] [Related]
34. Endothelium-dependent vasodilation in the isolated rabbit kidney following in vivo and in vitro ischaemia and reperfusion: effects of antagonizing platelet activating factor (PAF). Uluoglu C, Timlioglu O. Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep 27; 360(3):324-30. PubMed ID: 10543435 [Abstract] [Full Text] [Related]
35. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages. Chen J, Giri SN. J Pharmacol Exp Ther; 1997 Jun 27; 281(3):1047-58. PubMed ID: 9190835 [Abstract] [Full Text] [Related]
36. Selective inhibition of vasoconstrictor responses by platelet-activating factor in rat kidney. Handa RK, Strandhoy JW, Buckalew VM. Am J Physiol; 1991 Jul 27; 261(1 Pt 2):F108-16. PubMed ID: 1907104 [Abstract] [Full Text] [Related]
37. The synthesis, release and action of leukotrienes in the isolated, unstimulated, buffer-perfused rat heart. Garlick PB, Mashiter GD, Di Marzo V, Tippins JR, Morris HR, Maisey MN. J Mol Cell Cardiol; 1989 Nov 27; 21(11):1101-10. PubMed ID: 2607544 [Abstract] [Full Text] [Related]
38. Protective action of prostaglandin E1 (PGE1) against constrictor mediators in isolated rat heart and lung. Terashita Z, Stahl GL, Lefer AM. Biochem Pharmacol; 1988 Jul 01; 37(13):2659-65. PubMed ID: 2839198 [Abstract] [Full Text] [Related]